“We are excited to unleash the power of two organizations, now operating as one elite global solutions provider,” said Scott Ravech, CEO of Deerland, in the release. “Together, we are one step closer to achieving our vision of all people of all cultures benefiting from our enzyme, probiotic and prebiotic health products and science-backed technologies.”
As part of the integration process, Deerland announced, sales and marketing teams from the two companies addressed how the combined company would collaborate with customers to develop innovative and proprietary solutions. Additionally, the global research and development teams worked to ensure that each product offering would be supported with sound clinical science, and the manufacturing teams optimized production in the company’s four TGA and cGMP certified facilities around the globe.